WHO vaccine-preventable diseases: monitoring system. 2013 global summary

Last updated 20-Octl-2013 (data as of 16-Oct-2013)
Next overall update June 2014
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 10'0701 Infant (under 12 months) mortality rate: 492
GDP / capita (US$): 16'0861 Child (under 5 years) mortality rate: 662

Population data in thousands3

  2012  2011  2010  2009  2008  2000  1990  1980 
Total population 1'633  1'594  1'556  1'519  1'483  1'226  947  726 
Births 53  52  51  50  49  41  35  28 
Surviving infants 50  50  49  48  46  39  33  25 
Pop. less than 5 years 238  233  227  222  217  184  154  114 
Pop. less than 15 years 629  615  601  589  578  498  392  284 
Female 15-49 years 389  379  369  359  349  275  203  162 

Number of reported case

(Click for retrospective incidence data for Gabon)
Diphtheria
Japanese encephalitis
Measles 15  738  1'641 
Mumps
Pertussis 3'065 
Polio* 70 
Rubella 40  55 
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total) 22  12 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Gabon)
Vaccine year result method % card seen                                                
BCG 2011  95  EPI   83.0  79  76  68  71  75  48  97 
DTP1 2011  93  EPI   83.0  86  82  93  81  85  24 
DTP3 2011  85  EPI   83.0  82  75  67  76  82  10  78 
HepB_BD         
HepB3 2011  85  EPI   83.0  82  75  67  79  82 
Hib3 2011  85  EPI   83.0  82  75  67 
JapEnc         
MCV 2011  72  EPI   83.0  71  72  62  63  67  27  76 
MCV2         
PCV1         
PCV3         
Pol3 2011  85  EPI   83.0  80  75  68  74  81  52  78 
Rota1         
Rota_last         
Rubella1         
TT2plus 2011  38  EPI   83.0  59  57  51  58  53  16  86 
PAB         
VAD1          70  30 
YFV 2011  71  EPI   83.0  71  71  61  67  70 
  ° indicates that more than 1 survey occurred that year

  Next update: July 2014

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Gabon)
BCG 98  95  95  94  94  90  96 
DTP1 86  82  82  81  85  69  96 
DTP3 82  75  67  76  82  45  78 
HepB3 82  75  67  79  82 
Hib3 82  75  67 
MCV 71  72  62  63  67  55  76 
PAB 75  75  75  75  73  39  84 
PCV3
Pol3 80  75  68  74  81  44  78 
Rota_last
YFV 71  71  61  67  70 

Number of districts in the country 51  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
99 
   
/
|
|
\
Greater or equal to 90% 18
From 80 to 89% 22
From 50 to 79% 31
Less than 50% 29
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2012 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHep 6, 10, 14 weeks; Yes
Measles 9 months; Yes
OPV birth; 6, 10, 14 weeks; Yes
Pneumo_conj From January 2014
Rotavirus From January 2016
TT 1st contact pregnancy; +1, +6 months; +1, +1 year; Yes
YF 9 months; Yes

Immunizaton indicators

Indicator Expected answer 2012  2011  2010  2009  2008  2007  2006 

Planning and management

Multi-year plan (MYP) for immunization Yes/No/NR No  Yes  Yes  Yes  Yes  No  Yes 
What years does the MYP cover? number   2008-2011  2008-2011  2008-2011  2008-2011    2004-2008 
Nº of districts with microplans that include activities to raise immunization coverage number   50  37  25  20 

National Immunization Advisory Mechanism

Does the country have a standing technical advisory group on immunization? Yes/No/NR No    No         

System performance

Total number of districts in country number 51  51  51  51  51  51  51 
Nº districts with DTP3 coverage >=80% number 20  14  11  26  21  25 
% of districts with DTP3 coverage >=80% From 0 to 100% 39  27  22  51  41  49  18 
Nº districts with measles (MCV1) coverage >=95% number    
% of districts with MCV1 coverage >=95% From 0 to 100% 10     

Safety

Monitoring of Adverse Events Following Immunization (AEFI)? Yes/No/NR No  No  No  No  No  No  No 
Does your country have a vaccine adverse events review committee? Yes/No/NR/ND No  No  No         

Finance

Percentage of routine vaccines funded by Government From 0 to 100% 100  100  100  100  100  100  100 

Maternal and neonatal tetanus (NT) elimination

NT eliminated Yes/No No  No  No  No  No  No  No 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2012, data for 2011
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.